ATE489458T1 - Detoxifizym mit aktivität zur transformation von aflatoxin sowie das dafür codierende gen - Google Patents

Detoxifizym mit aktivität zur transformation von aflatoxin sowie das dafür codierende gen

Info

Publication number
ATE489458T1
ATE489458T1 AT05700424T AT05700424T ATE489458T1 AT E489458 T1 ATE489458 T1 AT E489458T1 AT 05700424 T AT05700424 T AT 05700424T AT 05700424 T AT05700424 T AT 05700424T AT E489458 T1 ATE489458 T1 AT E489458T1
Authority
AT
Austria
Prior art keywords
detoxifizyme
aflatoxin
adtz
transforming
activity
Prior art date
Application number
AT05700424T
Other languages
English (en)
Inventor
Dongsheng Yao
Daling Liu
Min Guan
Chunfang Xie
Original Assignee
Guangzhou Co Win Bioengineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Co Win Bioengineering Co Ltd filed Critical Guangzhou Co Win Bioengineering Co Ltd
Application granted granted Critical
Publication of ATE489458T1 publication Critical patent/ATE489458T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT05700424T 2004-08-17 2005-01-13 Detoxifizym mit aktivität zur transformation von aflatoxin sowie das dafür codierende gen ATE489458T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2004100511200A CN1294255C (zh) 2004-08-17 2004-08-17 一种具有转化黄曲霉毒素活性的解毒酶及编码该酶的基因
PCT/CN2005/000050 WO2006017960A1 (fr) 2004-08-17 2005-01-13 Enzyme de détoxification ayant une activité consistant à transformer l'aflatoxine et gène codant pour celle-ci

Publications (1)

Publication Number Publication Date
ATE489458T1 true ATE489458T1 (de) 2010-12-15

Family

ID=35718321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05700424T ATE489458T1 (de) 2004-08-17 2005-01-13 Detoxifizym mit aktivität zur transformation von aflatoxin sowie das dafür codierende gen

Country Status (16)

Country Link
US (1) US7695751B2 (de)
EP (1) EP1780270B1 (de)
JP (1) JP4495758B2 (de)
KR (1) KR100850640B1 (de)
CN (1) CN1294255C (de)
AT (1) ATE489458T1 (de)
AU (1) AU2005274578B2 (de)
BR (1) BRPI0513998A (de)
CA (1) CA2576069C (de)
DE (1) DE602005024973D1 (de)
HK (1) HK1106272A1 (de)
IL (1) IL180694A (de)
MX (1) MX2007001935A (de)
RU (1) RU2359032C2 (de)
WO (1) WO2006017960A1 (de)
ZA (1) ZA200700269B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294255C (zh) 2004-08-17 2007-01-10 广州科仁生物工程有限公司 一种具有转化黄曲霉毒素活性的解毒酶及编码该酶的基因
EP2231863B1 (de) 2007-12-14 2011-05-04 Novozymes A/S Verfahren zum abbau von zearalenon in einem futterprodukt unter verwendung von laccase
WO2009109607A2 (en) * 2008-03-05 2009-09-11 Novozymes A/S Detoxification of feed products
CN104130984B (zh) * 2014-07-30 2016-09-28 暨南大学 作用于杂色曲菌素的黄曲霉毒素氧化酶
CN104611305B (zh) * 2014-12-30 2017-11-17 暨南大学 胰蛋白酶抗性提高的黄曲霉毒素解毒酶
CN105112394A (zh) * 2015-09-11 2015-12-02 江南大学 一种能降解黄曲霉毒素b1的裂解酶的分离纯化方法
CN105400755B (zh) * 2015-12-09 2018-10-30 暨南大学 一种定点突变改造的人二肽基肽酶iii
CN105543250B (zh) * 2016-02-26 2018-12-21 广西大学 亮菌漆酶基因及其重组毕赤酵母工程菌和应用
CN107201377A (zh) * 2017-06-13 2017-09-26 山东仙普爱瑞科技股份有限公司 一种生产肝脏解毒酶的工程菌的构建及其应用
CN109370995B (zh) * 2018-12-11 2021-05-25 中国农业科学院北京畜牧兽医研究所 锰过氧化物酶CsMnP及其编码基因和应用
CN109557305B (zh) * 2019-01-09 2022-03-04 中粮集团有限公司 一种黄曲霉毒素b1降解酶及其应用和检测黄曲霉毒素b1的免疫层析试纸条
KR102114663B1 (ko) 2019-05-22 2020-05-25 한국식품연구원 아플라톡신 생성 균주의 생육억제 및 아플라톡신 생성 억제활성을 갖는 신규한 와이젤라 파라메센테로이데스 균주 및 이의 용도
CN115341010B (zh) * 2021-05-13 2024-10-18 华中农业大学 参与黄曲霉毒素b1毒性效应的靶点及其应用
CN114807074B (zh) * 2022-06-06 2023-10-13 江西省科学院生物资源研究所 一种黄曲霉毒素分解酶及其编码基因、重组载体、重组菌及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919685A (en) * 1997-08-08 1999-07-06 Incyte Pharmaceuticals, Inc. Human aflatoxin B1 aldehyde reductase
CN1113098C (zh) * 1998-06-30 2003-07-02 广东药学院 黄曲霉毒素b1的解毒酶提取工艺
JP2002526107A (ja) * 1998-10-07 2002-08-20 マキシジェン， インコーポレイテッド マイコトキシンの解毒のための核酸を生成するためのｄｎａシャッフリング
CN1085057C (zh) * 1999-10-27 2002-05-22 广东省技术开发中心暨南大学 黄曲霉毒素b1解毒酶去除黄曲霉毒素b1的方法
CN1294255C (zh) 2004-08-17 2007-01-10 广州科仁生物工程有限公司 一种具有转化黄曲霉毒素活性的解毒酶及编码该酶的基因

Also Published As

Publication number Publication date
CA2576069C (en) 2011-05-17
US7695751B2 (en) 2010-04-13
WO2006017960A1 (fr) 2006-02-23
HK1106272A1 (en) 2008-03-07
IL180694A (en) 2012-01-31
EP1780270B1 (de) 2010-11-24
IL180694A0 (en) 2007-06-03
JP2008509684A (ja) 2008-04-03
DE602005024973D1 (de) 2011-01-05
RU2007103735A (ru) 2008-09-27
EP1780270A4 (de) 2007-10-24
BRPI0513998A (pt) 2008-05-20
KR20070032796A (ko) 2007-03-22
KR100850640B1 (ko) 2008-08-07
CN1294255C (zh) 2007-01-10
US20080260711A1 (en) 2008-10-23
CN1712526A (zh) 2005-12-28
ZA200700269B (en) 2008-05-28
EP1780270A1 (de) 2007-05-02
RU2359032C2 (ru) 2009-06-20
CA2576069A1 (en) 2006-02-23
JP4495758B2 (ja) 2010-07-07
AU2005274578A1 (en) 2006-02-23
AU2005274578B2 (en) 2008-02-28
MX2007001935A (es) 2007-04-17

Similar Documents

Publication Publication Date Title
ATE489458T1 (de) Detoxifizym mit aktivität zur transformation von aflatoxin sowie das dafür codierende gen
IL172270A (en) Biologically active neoblastin and methods for its preparation
WO2002074964A3 (fr) Polypeptides derives des arn polymerases, et leurs utilisations
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
DE60232870D1 (de) Neue polynukleotide und polypeptide des erythropoietingens
EP1364966A3 (de) Herstellung des rekombinanten menschlichen Epidermis-Wachstumsfaktors in Pflanzen
ATE334231T1 (de) Neue polynukleotide und polypeptide des ifn alpha-17-gens
ATE401393T1 (de) Rekombinante proteinase k
EP0815233A4 (de) Neue cytokinine aus vögeln und dafür codierende genetische sequenzen
DK0674714T3 (da) Rekombinant gastrisk lipase fra hunde og farmaceutiske sammensætninger
FR2792651A1 (fr) Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations
EP1236800A3 (de) Für Interferon alfa 2 codierende Nukleinsäuren die Einzelnukleotidpolymorphismen enthalten und Methoden zu deren Verwendung
JP2003334089A5 (de)
WO2002099092A8 (en) Production of recombinant human lysosomal alpha-mannosidase
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner
ATE382698T1 (de) Ein gen kodierend für vitamin b6-phosphat- phosphatase und deren verwendung
WO2007128545A3 (en) Mac30 gene
WO2007128553A3 (en) Mig12
WO2003040343A3 (en) Polynucleotide and polypeptide sequences of canine cathepsin s
DE69830528D1 (de) Cytochrom P450 Gen
ATE482274T1 (de) Polypeptid mit amidaseaktivität und dessen gen
MX9605473A (es) Polipeptido hk2 recombinante.
Saini et al. Research Article Characterisation and In Silico Analysis of Interleukin-4 cDNA of Nilgai (Boselaphus tragocamelus) and Indian Buffalo (Bubalus bubalis)
ATE448311T1 (de) Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1780270

Country of ref document: EP